Loading... (0%)
About liver disease

GENFIT announces Pivotal Phase 3 Clinical Trial of Elafibranor in Nash following Regulatory Input

in sem, suscipit fringilla Aliquam et, vulputate, libero. ut id, tristique Phasellus